The prevalence of daily low-dose aspirin use fell significantly after the American College of Cardiology and the American Heart Association narrowed ...
A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
We have yet to find the cure for cancer, but there are ways to treat the disease and mitigate your risk of dying from it - ...
Safe aspirin elimination in patients with HeartMate 3 LVAD reduces bleeding risk, offering key clinical practice insights.
For decades, aspirin has been the standard preventive treatment for patients with blood vessel disease. After an acute ...
From bone to heart health, aspirin has been linked to all kinds of benefits through the years — though many of these benefits ...
Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds ...
ECA stack combines ephedrine, caffeine, and aspirin. It is marketed to help promote weight loss and atheletic performance—but ...
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.
People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...